Phaseline

Targets › MTB

MTB: drug programs, companies and trials

1 program from 1 company in 3 trials: 3 Phase 2; Infectious disease.

Open in Phaseline: the race on MTB, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Bharat Biotech InternationalMTBVAC (BBV169)
Live attenuated Mycobacterium tuberculosis vaccine
MTBPhase 2Tuberculosis (TB); HIV I Infection–

Conditions

Tuberculosis (TB) (2) HIV I Infection (1)

Modalities

protein or peptide (1)

Companies

Bharat Biotech International (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.